Brookfield Infrastructure Partners L.P. (TSX:BIP.UN)
Canada · Delayed Price · Currency is CAD 42.91
-0.16 (-0.37%)
Aug 1, 2025, 4:00 PM EDT
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 76 | 74 | 125 | 125 | 654 | 156 | Upgrade |
Depreciation & Amortization | 3,727 | 3,644 | 2,739 | 2,158 | 2,036 | 1,705 | Upgrade |
Loss (Gain) on Equity Investments | 70 | -156 | 323 | 563 | 69 | 36 | Upgrade |
Other Operating Activities | 1,378 | 1,317 | 1,529 | 1,189 | 537 | 853 | Upgrade |
Change in Accounts Receivable | 136 | 136 | -124 | -445 | -190 | 284 | Upgrade |
Change in Accounts Payable | -349 | -349 | -43 | -342 | -323 | -89 | Upgrade |
Change in Other Net Operating Assets | -226 | -13 | -471 | -117 | -11 | -415 | Upgrade |
Operating Cash Flow | 4,812 | 4,653 | 4,078 | 3,131 | 2,772 | 2,530 | Upgrade |
Operating Cash Flow Growth | 7.20% | 14.10% | 30.25% | 12.95% | 9.56% | 18.06% | Upgrade |
Capital Expenditures | -3,757 | -4,975 | -2,487 | -2,775 | -2,067 | -1,472 | Upgrade |
Sale of Property, Plant & Equipment | 871 | 609 | 162 | 41 | 85 | 46 | Upgrade |
Cash Acquisitions | -2,523 | -2,523 | -10,747 | -479 | -2,923 | -3,405 | Upgrade |
Divestitures | 77 | 77 | 602 | 198 | 3,284 | 745 | Upgrade |
Investment in Securities | 1,133 | - | 200 | -528 | 429 | -606 | Upgrade |
Other Investing Activities | 80 | -89 | -720 | 178 | 19 | 83 | Upgrade |
Investing Cash Flow | -4,119 | -6,901 | -12,990 | -3,365 | -1,173 | -4,609 | Upgrade |
Short-Term Debt Issued | - | - | 525 | 33 | 431 | - | Upgrade |
Long-Term Debt Issued | - | 27,612 | 20,536 | 13,105 | 22,682 | 9,036 | Upgrade |
Total Debt Issued | 23,749 | 27,612 | 21,061 | 13,138 | 23,113 | 9,036 | Upgrade |
Short-Term Debt Repaid | - | -139 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -19,317 | -15,690 | -9,754 | -21,830 | -7,528 | Upgrade |
Total Debt Repaid | -19,203 | -19,456 | -15,690 | -9,754 | -21,830 | -7,528 | Upgrade |
Net Debt Issued (Repaid) | 4,546 | 8,156 | 5,371 | 3,384 | 1,283 | 1,508 | Upgrade |
Issuance of Common Stock | 11 | 11 | - | 13 | 1,073 | 9 | Upgrade |
Repurchase of Common Stock | - | - | -13 | - | - | - | Upgrade |
Preferred Dividends Paid | -40 | -40 | -38 | -38 | -41 | -35 | Upgrade |
Common Dividends Paid | -748 | -748 | -701 | -660 | -608 | -588 | Upgrade |
Dividends Paid | -839 | -788 | -739 | -698 | -649 | -623 | Upgrade |
Other Financing Activities | -3,384 | -4,767 | 4,800 | -2,409 | -2,703 | 1,032 | Upgrade |
Financing Cash Flow | 334 | 2,612 | 9,419 | 56 | -995 | 2,126 | Upgrade |
Foreign Exchange Rate Adjustments | 17 | -150 | 71 | 88 | -65 | -7 | Upgrade |
Miscellaneous Cash Flow Adjustments | -28 | - | - | -37 | - | - | Upgrade |
Net Cash Flow | 1,016 | 214 | 578 | -127 | 539 | 40 | Upgrade |
Free Cash Flow | 1,055 | -322 | 1,591 | 356 | 705 | 1,058 | Upgrade |
Free Cash Flow Growth | 106.86% | - | 346.91% | -49.50% | -33.37% | 10.09% | Upgrade |
Free Cash Flow Margin | 4.90% | -1.53% | 8.87% | 2.47% | 6.11% | 11.91% | Upgrade |
Free Cash Flow Per Share | 2.29 | -0.70 | 3.46 | 0.78 | 1.58 | 2.39 | Upgrade |
Cash Interest Paid | 3,289 | 3,289 | 2,132 | 1,638 | 1,074 | 985 | Upgrade |
Cash Income Tax Paid | 597 | 597 | 524 | 364 | 262 | 172 | Upgrade |
Levered Free Cash Flow | -268.5 | -755.13 | 498.88 | -1,207 | 1,768 | 2,925 | Upgrade |
Unlevered Free Cash Flow | 1,966 | 1,362 | 2,062 | -47.5 | 2,686 | 3,662 | Upgrade |
Change in Net Working Capital | 1,296 | 406 | 720 | 1,608 | -914 | -2,163 | Upgrade |
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.